弱视与成人健康:全国队列中系统性、感觉及精神共病的综合分析
基于All of Us研究项目1998例弱视成人(其中1335例非斜视性、663例斜视性,含187例Fitbit数据)的横断面研究,按10:1倾向评分匹配对照组。弱视与双侧盲、肥胖、2型糖尿病、心血管疾病及多种神经精神障碍的患病 odds 升高相关,且每日步数更少。结论提示弱视与长期系统性健康问题相关,需早期发现和干预。
要点
- 弱视成人双侧盲、肥胖、2型糖尿病及心血管疾病的 odds 均升高。
- 弱视成人每日步数少于对照,提示体力活动减少。
- 多种神经精神障碍(如焦虑、多动、强迫、自闭症)与弱视相关,但精神分裂症无关联。
核心结论
- 弱视与长期系统性健康问题相关,可能反映视力损害的长期影响或共同潜在风险因素。
- 研究结果强调弱视早期发现和干预的必要性,并需进一步探索连接弱视与共病的神经发育通路。
研究设计与样本
- 横断面研究,使用美国国立卫生研究院All of Us研究项目数据。
- 纳入1998例弱视成人(1335例非斜视性、663例斜视性),其中187例有Fitbit数据。
- 对照组按10:1比例,基于年龄、性别、自报种族、收入和就诊次数进行倾向评分匹配,Fitbit及亚组分析使用单独匹配对照组。
主要发现
- 弱视与双侧盲(OR=2.96,95% CI 2.54至3.44)、肥胖(OR=1.27,95% CI 1.16至1.39)、2型糖尿病(OR=1.39,95% CI 1.26至1.53)和心血管疾病(OR=1.92,95% CI 1.69至2.19)的 odds 升高相关。
- 弱视个体每日步数更少(5859 vs 6229;p=0.044),表明体力活动减少。
- 神经精神障碍更常见,包括广泛性焦虑(OR=1.57,95% CI 1.43至1.72)、物质使用障碍(OR=1.40,95% CI 1.25至1.55)、双相障碍(OR=1.35,95% CI 1.13至1.61)、注意缺陷/多动障碍(OR=1.54,95% CI 1.28至1.86)、强迫症(OR=1.82,95% CI 1.31至2.54)和自闭症(OR=3.27,95% CI 1.79至5.99)。
- 精神分裂症与弱视无关联(OR=1.00,95% CI 0.70至1.42)。
临床怎么用
- 对弱视患者应关注全身共病风险,包括肥胖、2型糖尿病、心血管疾病及神经精神障碍,并鼓励体力活动。
- 弱视的早期检测和干预可能对长期健康有重要意义。
局限性
- 横断面设计无法确定因果关系。
- 弱视识别依赖ICD-9/ICD-10/SNOMED编码,可能存在错分。
- Fitbit数据仅来自187例弱视个体,体力活动结果代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To evaluate the adult health consequences of amblyopia, including sensory deficits, mental health, physical activity and cardiovascular health. METHODS: A cross-sectional study using data from the National Institutes of Health's All of Us Research Program, including 1998 adults with amblyopia (1335 non-strabismic, 663 strabismic) identified by International Classification of Diseases (ICD)-9/ICD-10/Systemized Nomenclature of Medicine (SNOMED) codes, including 187 with Fitbit data. Controls (10:1 ratio) were propensity-score-matched on age, sex, self-reported race, income and healthcare visits. Separate matched control groups were used for Fitbit and subgroup analyses. Data from electronic health records, surveys and Fitbit were used to assess sensory impairments, cardiometabolic conditions, physical activity and neuropsychiatric disorders. Prevalence and ORs with 95% CIs were calculated to assess associations between amblyopia (total, strabismic and non-strabismic) and health outcomes. RESULTS: Amblyopia was associated with increased odds of bilateral blindness (OR=2.96, 95% CI 2.54 to 3.44), obesity (OR=1.27, 95% CI 1.16 to 1.39), type 2 diabetes (OR=1.39, 95% CI 1.26 to 1.53) and cardiovascular disease (OR=1.92, 95% CI 1.69 to 2.19). Amblyopic individuals took fewer daily steps (5859 vs 6229; p=0.044), indicating decreased physical activity. Neuropsychiatric disorders were more common, including generalised anxiety (OR=1.57, 95% CI 1.43 to 1.72), substance use disorder (OR=1.40, 95% CI 1.25 to 1.55), bipolar disorder (OR=1.35, 95% CI 1.13 to 1.61), attention-deficit/hyperactivity disorder (OR=1.54, 95% CI 1.28 to 1.86), obsessive compulsive disorder (OR=1.82, 95% CI 1.31 to 2.54) and autism (OR=3.27, 95% CI 1.79 to 5.99). Schizophrenia was not associated (OR=1.00, 95% CI 0.70 to 1.42). CONCLUSIONS: Amblyopia is associated with long-term systemic health conditions, suggesting either long-term effects of visual impairment or shared underlying risk factors. These findings underscore the need for early detection and intervention. Further research is needed to explore the neurodevelopmental pathways linking amblyopia and its comorbidities.
引用
- Lee KAV, Langholm C, Lin T, et al. Amblyopia and adult health: a comprehensive analysis of long-term systemic, sensory and mental health comorbidities in a national cohort. Br J Ophthalmol. 2026. PMID: 41592945. doi:10.1136/bjo-2025-328653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。